RVL Pharmaceuticals PLC RVLP

Market cap
$14.1M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22
Cash and Short Term Investments
19.56 34.74 70.83 95.87 114.05 40.44 44.54
Receivables
45.32 37.64 56.42 43.91 3.15 2.13 3.03
Inventory
19.84 16.95 24.38 21.31 1.83 0.84 0.78
Other current assets
9.49 25.50 20.72 11.55 41.53 3.06 8.62
Total current assets
94.21 114.83 172.36 172.63 173.15 59.38 56.98
Property, Plant, Equpment (Net)
27.73 31.41 31.26 30.24 2.39 0.87 1.28
Goodwill and Intangible Assets (Total)
854.11 772.56 591.25 254.84 90.94 83.06 69.75
Long-term assets (Other)
2.45 0.94 0.75 0.56 102.51 — —
Total non-current assets
884.29 804.91 623.26 290.63 197.80 85.29 71.54
Total Assets
978.50 919.74 795.62 463.26 370.95 144.67 128.51
Accounts Payable
34.98 36.07 24.87 8.50 3.13 3.78 2.41
Accrued Expenses
64.71 81.93 87.24 65.25 16.95 13.08 15.40
Current Part of Debt
5.17 6.66 1.77 2.19 1.22 2.41 1.43
Current Part of Capital Lease
0.11 0.02 0.12 0.13 0.02 0.01 0.01
Current Part of Taxes to Pay
— — 0.39 — 0.00 0.00 0.04
Other current liabilities
12.86 81.93 87.24 65.25 34.48 13.08 15.40
Total current liabilities
117.83 124.68 114.00 75.94 55.78 20.11 19.72
Long Term Debt (Total)
323.74 314.01 266.94 267.99 219.53 43.80 55.52
Long Term Tax Liability (Deferred)
67.56 42.89 28.29 1.50 0.35 0.15 0.06
Non-current Liabilities (Other)
4.16 2.38 2.54 0.00 0.57 3.29 2.02
Total non-current liabilities
395.46 359.28 297.78 272.61 221.31 47.83 57.69
Total liabilities
513.30 483.96 411.78 348.55 277.09 67.94 77.42
Additional Paid In Capital
— — 487.29 489.44 548.07 591.73 619.32
Common Stock (Net)
464.93 436.42 0.53 0.52 0.63 0.83 0.99
Retained Earnings
— — (102.12) (373.02) (452.61) (517.53) (569.22)
Shareholders Equity (Other)
464.93 436.42 — — — — —
Common Equity (Total)
465.21 435.78 383.85 114.71 93.86 76.73 51.09
Shareholders Equity (Total)
465.21 435.78 383.85 114.71 93.86 76.73 51.09
Shareholders Equity and Liabilities (Total)
978.50 919.74 795.62 463.26 370.95 144.67 128.51
Shares (Common)
— — 52.52 51.85 62.55 83.30 99.16
Shareholders Equity (Tangible)
(388.90) (336.78) (207.40) (140.13) 2.92 (6.32) (18.65)
Net Debt
309.35 285.92 197.88 174.32 106.69 5.77 12.41
Total Debt
328.91 320.66 268.72 270.18 220.74 46.21 56.95

Fold the line items

In millions of $ except per-share values · columns are period end dates